Filing metadata

Accession number
0001493152-21-026383
Form type
Form 4
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Oct 26, 2021
Reporting period
Oct 22, 2021
Description
Insider transaction

Explore SEC Filings Hub